ArticlePharmacoEconomics - open2023

Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.

Ahmed Salem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.